Valuation: Krka, d. d.

Market Cap 7.87B 9.03B 7.43B 6.75B 12.65B 866B 12.7B 89.04B 34.36B 440B 33.91B 33.16B 1,417B P/E 2026 *
18.6x
P/E 2027 * 17.7x
Enterprise Value 7.3B 8.37B 6.89B 6.26B 11.72B 803B 11.77B 82.55B 31.85B 408B 31.44B 30.74B 1,314B EV / Sales 2026 *
3.37x
EV / Sales 2027 * 3.14x
Free-Float
74.74%
Yield 2026 *
3.79%
Yield 2027 * 3.98%
1 day-0.95%
Current month-1.14%
3 months-0.95%
6 months+12.07%
Current year+28.08%
1 week 259.5
Extreme 259.5
263
1 month 257.5
Extreme 257.5
267
Current year 202
Extreme 202
270
1 year 174
Extreme 174
270
3 years 104.5
Extreme 104.5
270
5 years 80
Extreme 80
270
10 years 48.01
Extreme 48.01
270
Manager TitleAgeSince
Chief Executive Officer 71 01/01/2005
Director of Finance/CFO - 01/01/2026
Chief Tech/Sci/R&D Officer - 01/03/2023
Director TitleAgeSince
Director/Board Member 59 01/01/2005
Director/Board Member 59 01/01/2005
Director/Board Member 73 01/01/2010
Change 5-day change 1-year change 3-year change Capi.($)
-0.95%0.00%+18.72%+150.00% 9.03B
-1.61%-0.15%+11.45%+60.09% 45.94B
-1.02%-1.90%+35.99%+100.50% 37.22B
+2.19%+3.65%+10.70%+80.29% 12.06B
+1.32%+2.09%-11.64%+12.41% 11.74B
+0.39%+2.39%+29.99%+38.63% 7.36B
-0.06%+2.97%+38.90%-18.67% 7.15B
+1.30%+1.17%+16.08%+187.41% 7.2B
+0.70%+1.10%-44.22%+5.78% 5.03B
+1.80%+0.85%+39.84%+113.77% 4.64B
Average +0.41%+1.06%+14.58%+73.02% 14.74B
Weighted average by Cap. -0.37%+0.24%+17.67%+74.82%

Financials

2026 *2027 *
Net sales 2.16B 2.48B 2.04B 1.86B 3.48B 238B 3.49B 24.48B 9.45B 121B 9.33B 9.12B 390B 2.29B 2.63B 2.17B 1.97B 3.68B 252B 3.7B 25.94B 10.01B 128B 9.88B 9.66B 413B
Net income 430M 493M 406M 369M 691M 47.35B 694M 4.87B 1.88B 24.07B 1.85B 1.81B 77.46B 455M 521M 429M 390M 730M 50.03B 733M 5.14B 1.98B 25.43B 1.96B 1.91B 81.84B
Net Debt -574M -658M -542M -492M -922M -63.12B -925M -6.49B -2.5B -32.09B -2.47B -2.42B -103B -680M -780M -642M -583M -1.09B -74.85B -1.1B -7.69B -2.97B -38.05B -2.93B -2.87B -122B
Logo Krka, d. d.
Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.
Employees
13,300
Date Price Change Volume
18/09/26 €260.00 -0.95% 4,699
17/09/26 €262.50 0.00% 4,516
16/09/26 €262.50 +0.96% 5,111
15/09/26 €260.00 -0.95% 4,250
14/09/26 €262.50 +0.96% 1,687
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
260.00EUR
Average target price
257.83EUR
Spread / Average Target
-0.83%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KRKG Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!